Krebs Biochemicals & Industries opened lower at ₹55.81, compared with its previous close of ₹56.64. During today's session, the stock has traded between ₹55.75 and ₹59.80, with an average traded price of ₹57.06. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Krebs Biochemicals & Industries is now worth
₹ 3,379.00
resulting in a loss of
₹ 6,621.00 (66.21%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.65 (+1.15%)
Day High
₹59.80
Day Low
₹55.75
Day Open
₹55.81
Prev Close
₹56.64
Volume
8,398
Value Traded
₹0.05 Cr
1W Return
-10.43%
1M Return
-2.44%
3M Return
3.17%
6M Return
-7.36%
1Y Return
-20.15%
Market Cap (₹ Cr.)
124
PE Ratio
-8.70
PB Ratio
-0.75
Dividend Yield
-
ROE
10.40%
ROCE
-19.62%
Book Value (₹)
-75.49
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-10.43%
6 Week
-
1 Month
-2.44%
3 Month
3.17%
9 Month
-8.57%
No data available.
Citurgia Biochemicals seeks two-month extension for 51st AGM
Citurgia Biochemicals board approved seeking a two-month extension for its 51st AGM. Current AGM deadline is October 31, 2026, following an earlier one-month ROC extension. Delays attributed to increased post-listing compliance and Company Secretary resignation. Board meeting held on October 6, 2026, to finalize the application to ROC Mumbai.
7 days agoCiturgia Biochemicals closes trading window ahead of Q2FY27 results
Trading window closed from October 1, 2026. Window reopens 48 hours after Q2FY27 results declaration. Closure complies with SEBI (Prohibition of Insider Trading) Regulations, 2015. Board meeting date for results approval to be announced later.
13 days agoKrebs Biochemicals shareholders pass all five resolutions at 34th AGM
All five ordinary resolutions at the 34th AGM passed with requisite majority. Promoter group voted unanimously in favour of financials and director reappointments. Public non-institutional shareholders registered minor dissent, peaking at 3.41% on director reappointment. Resolution on related party transactions passed with 96.58% support from eligible public voters.
14 days agoCiturgia cites comms gap for delay in disclosing AGM extension
Citurgia Biochemicals missed the 24-hour disclosure deadline for ROC AGM extension approval. Internal communication gaps and confirmation delays cited as reasons for the lapse. ROC approved a one-month extension moving the AGM deadline to October 31, 2026. Company has strengthened internal reporting mechanisms to prevent future compliance failures.
18 days agoCiturgia Biochemicals Q1FY27 Results: Loss narrows 68% YoY to ₹8.20 lakh
Citurgia Biochemicals reported a Q1FY27 net loss of ₹8.20 lakh, down from ₹8.39 lakh YoY. Total income from operations remained at zero for the quarter and full year. Total expenses dropped 68% QoQ to ₹8.20 lakh due to lower other expenses. Employee benefits stayed flat at ₹3.00 lakh; depreciation fell to ₹5.15 lakh.
1mo agoCiturgia Biochemicals accepts resignation of Company Secretary Yatendra Kumar
Citurgia Biochemicals accepted Yatendra Kumar's resignation as Company Secretary effective July 24, 2026. Kumar is leaving to pursue career opportunities outside the organization. The company filed additional details on September 8, 2026, to rectify a delayed submission of the resignation letter. Whole Time Director Kashi Nath assured future compliance with SEBI LODR Regulations.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Krebs Biochemicals & Industries is now worth
₹ 3,379.00
resulting in a loss of
₹ 6,621.00 (66.21%)
Note: Past profits do not guarantee future returns.